Latest News

What Biotech CEOs (And Their Funders) Learned From The Theranos Debacle

August 2, 2017 | Biotech investors are still stunned by the rise and fall of the one-drop blood testing startup. But they're hellbent on making sure they don’t all get burned again. WIRED